PL EN


Preferences help
enabled [disable] Abstract
Number of results
2016 | 70 | 265–273
Article title

Arterial blood pressure circadian rhythm in normotensive decompensated cirrhotic patients before and after single paracentesis

Content
Title variants
PL
Rytm okołodobowy ciśnienia tętniczego krwi u normotensyjnych pacjentów z niewyrównaną marskością wątroby przed i po paracentezie
Languages of publication
EN
Abstracts
EN
INTRODUCTION: Decompensated liver cirrhosis is associated with hemodynamic changes including arterial blood pressure alterations. The aim of the study was to investigate the circadian rhythm variability of arterial blood pressure in relation to reninemia and aldosteronemia in cirrhotic patients with ascites, before and after paracentesis. MATERIAL AND METHODS: The study was performed in 22 normotensive cirrhotics with ascites and 19 healthy controls. Ambulatory arterial blood pressure monitoring was conducted for 24 hours, cardiac output and systemic vascular resistance were determined and circulating renin and aldosterone concentrations were measured. In cirrhotics, the tests were repeated 24 hours after paracentesis. RESULTS: It was demonstrated that as a consequence of paracentesis, the mesor values of systolic and diastolic blood pressure and heart rate decreased, whereas the amplitudes did not change in the cirrhotics. Moreover, in the cirrhotics' acrophases of blood pressure occurred earlier than in the controls. The day-night differences of mean pressure values were smaller in the cirrhotics than in the controls. The patients before paracentesis demonstrated higher cardiac output and lower systemic vascular resistance than healthy subjects. In cirrhotic patients the renin and aldosterone concentrations were higher and the aldosterone/renin ratio was lower than in the controls. CONCLUSIONS: Arterial blood pressure circadian rhythm in normotensive patients with decompensated cirrhosis of the liver with ascites is characterized by a lowered decrease at nighttime that suggests the occurrence of non-dipping phenomenon. The reduction of ascites in patients with decompensated liver cirrhosis leads to a reduction in arterial blood pressure and does not eliminate the non-dipping phenomenon in its day-night rhythm. In normotensive cirrhotic patients with ascites before and after single paracentesis, a dissociation of the renin-aldosterone nexus occurs.
PL
WSTĘP: Niewyrównana marskość wątroby prowadzi do zaburzeń hemodynamicznych i zmian ciśnienia tętniczego krwi. Celem pracy było badanie zmienności okołodobowego rytmu ciśnienia tętniczego z uwzględnieniem reninemii i aldosteronemii u pacjentów z marskością wątroby z wodobrzuszem, przed i po paracentezie. MATERIAŁ I METODY: Badania obejmowały 22 chorych na marskość wątroby z wodobrzuszem i 19 osób zdrowych stanowiących grupę kontrolną. Przeprowadzono 24-godzinny pomiar ciśnienia tętniczego krwi, określono objętość minutową serca, całkowity opór obwodowy naczyń oraz stężenie reniny i aldosteronu w surowicy. U chorych na marskość wątroby badania powtórzono po 24 godz. od wykonania paracentezy. WYNIKI: W następstwie paracentezy mezory wartości ciśnienia skurczowego i rozkurczowego oraz tętna obniżyły się, amplituda zaś nie uległa zmianie. U chorych akrofazy ciśnienia krwi wystąpiły wcześniej niż w grupie kontrolnej. Różnice dzienno-nocne wartości ciśnienia krwi u chorych na marskość wątroby okazały się mniejsze niż u osób zdrowych. U chorych przed paracentezą objętość minutowa serca była większa, a całkowity opór obwodowy naczyń mniejszy niż u osób z grupy kontrolnej. W porównaniu z grupą kontrolną, reninemia i aldosteronemia były większe, natomiast wskaźnik aldosteron/renina mniejszy u chorych na marskość wątroby. WNIOSKI: U normotensyjnych chorych na marskość wątroby z wodobrzuszem występuje zjawisko non-dipper. Paracenteza prowadzi do zmniejszenia ciśnienia tętniczego, lecz nie znosi zjawiska non-dipper. U chorych na marskość wątroby z wodobrzuszem obserwuje się rozkojarzenie reninowo-aldosteronowe zarówno przed, jak i po paracentezie.
Discipline
Year
Volume
70
Pages
265–273
Physical description
References
  • 1. Henriksen J.H., Fuglsang S., Bandtsen F., Møller S. Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics. Gut 2006; 55: 380–387.
  • 2. Meng H.C., Lin H.C., Tsai Y.T. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis. J. Gastroenterol. Hepatol. 1994; 9: 148–153.
  • 3. Bernardi M., Trevisani F., Santini C., De Palma R., Gasbarrini G. Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. Gut 1983; 24: 761–766.
  • 4. Kuiper J.J., Boomsma F., van Buren H., de Man R., Danser A.H.J., van den Meiracker A.H. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis. Eur. J. Clin. Invest. 2008; 38: 939–944.
  • 5. Vila M.C., Solà R., Molina L., Andreu M., Coll S., Gana J., Marquez J., Palá J., Bory F., Pons S., Szescielinski L., Jimenez W. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. J. Hepatol. 1998; 28: 639–645.
  • 6. Genesca J., Segura R., Gonzalez A., Catalan R., Marti R., Torregrosa M., Cereto F., Martinez M., Esteban R., Guardia J. Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients. Am. J. Gastroenterol. 2000; 95: 1539–1544.
  • 7. Henriksen J.H., Møller S., Schifter S., Bendtsen F. Increased arterial compliance in decompensated cirrhosis. J. Hepatol. 1999; 31: 712–718.
  • 8. Kojima H., Tsujimoto T., Uemura M., Takaya A., Okamoto S., Ueda S., Nishio K., Miyamoto S., Kubo A., Minamino N., Kangawa K., Matsuo H., Fukui H. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis. J. Hepatol. 1998; 28: 840–846.
  • 9. Sharma P., Kumar A., Jha S., Mishra S.R., Sharma B.C., Sarin S.K. The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment. Pharmacol. Ther. 2010; 32: 105–112.
  • 10. Winkler C., Hobolth L., Krag A., Bendtsen F., Møller S. Effect of treatment with β-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosis. Eur. J. Gastroenterol. Hepatol. 2011; 23: 334–342.
  • 11. Rajesh P.P., Srinivasan R., Jayanthi V. Prevalence of arterial hypertension in cirrhosis of liver. Saudi. J. Gastroenterol. 2009; 15: 65–66.
  • 12. Cabrera J., Falcon L., Gorriz E., Pardo M.D., Granados R., Quinones A., Maynar M. Abdominal decompression plays a major role in early postparacentesis haemodynamic changes in cirrhotic patients with tense ascites. Gut 2001; 48: 384–389.
  • 13. Carl D.E., Ghosh S., Cheng J., Gehr T.W., Stravitz R.T., Sanyal A. Post-paracentesis circulatory derangements are related to monocyte activation. Liver Int. 2014; 34: 1001–1007.
  • 14. Nasr G., Hassan A., Ahmed S., Serwah A. Pre¬dictors of large paracentesis induced circulatory dysfunction in patients with massive hepatic ascites. J. Cardiovasc. Dis. Res. 2010; 1: 136–144.
  • 15. Møller S., Christensen E., Henriksen J.H. Continuous blood pressure monitoring in cirrhosis. Relations to splanchnic and systemic haemodynamics. J. Hepatol. 1997; 27: 284–294.
  • 16. Møller S., Wiinberg N., Henriksen J.H. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995; 22: 88–95.
  • 17. Tzamouranis D.G., Alexopoulou A., Dourakis S.P., Stergiou G.S. Relationship of 24-hour ambulatory blood pressure and heart rate with markers of hepatic function in cirrhotic patients. BMC Gastroenterology 2010; 10: 143–150.
  • 18. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646–649.
  • 19. Wiesner R.H., McDiarmid S.V., Kamath P.S., Edwards E.B., Malinchoc M., Kremers W.K., Krom R.A., Kim W.R. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001; 7: 567–580.
  • 20. Pöge U., Gerhardt T., Stoffel-Wagner B., Klehr H.U., Sauerbruch T., Woitas R.P. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol. Dial. Transplant. 2006; 21: 660–664.
  • 21. Manabe Y., Murakami T., Iwatsuki K., Narai H., Warita H., Hayashi T., Shoji M., Imai Y., Abe K. Nocturnal blood pressure dip in CADASIL. J. Neurol. Sci. 2001; 193: 13–16.
  • 22. Lazzeri C., La Villa G., Laffi G., Vecchiarino S., Gambilonghi F., Gentilini P., Franchi F. Autonomic regulation of heart rate and QT interval in nonalcoholic cirrhosis with ascites. Digestion 1997; 58: 580–586.
  • 23. Trevisani F., Sica G., Mainquà P., Santese G., De Notariis S., Caraceni P., Domenicali M., Zacà F., Grazi G.L., Mazziotti A., Cavallari A., Bernardi M. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology 1999; 30: 1387–1392.
  • 24. Alvarez D., Golombek D., Lopez P., de las Heras M., Viola L., Sanchez S., Kolker M., Mastai R. Diurnal fluctuations of portal and systemic hemodynamic parameters in patients with cirrhosis. Hepatology 1994; 20: 1198–1203.
  • 25. Birkenhäger A.M., van den Meiracker A.H. Causes and consequences of a non-dipping blood pressure profile. Neth. J. Med. 2007; 65: 127–131.
  • 26. Kogan J., Turkot S., Golzman B., Oren S. Small artery compliance in cirrhotic patients during total paracentes. Isr. Med. Assoc. J. 2005; 7: 233–236.
  • 27. Peltekian K.M., Wong F., Liu P.P., Logan A.G., Sherman M., Bendis L.M. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am. J. Gastroenterol. 1997; 92: 394–399.
  • 28. Møller S., Bendtsen F., Henriksen J.H. Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume. Scand. J. Gastroenterol. 2006; 41: 451–458.
  • 29. Plouin P.F., Cudek P., Arnal J.F., Guyene T.T., Corvol P. Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure and liver cirrhosis. Horm. Res. 1990; 34: 138–141.
  • 30. Lu P., Liu H., Yin H., Yang L. Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells. Med. Sci. Monit. 2011; 17: BR248–256.
Document Type
article
Publication order reference
YADDA identifier
bwmeta1.element.psjd-10a1c18c-84cb-4bbc-a821-9bc13198b59f
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.